Patients News | pharmaphorum

News

RNA blood test may predict antidepressant response

Selective serotonin reuptake inhibitors (SSRIs) are the first-line drug therapy of choice for most people suffering from depression but often fail to work effectively.

News

Pfizer pauses DMD gene therapy trial after boy’s death

The death of a young boy with Duchenne muscular dystrophy (DMD) who was treated with Pfizer’s experimental gene therapy in a phase 2 trial has prompted the company to paus

News

Sorcero GenAI conjures plain language from scientific papers

Understanding complex scientific studies is often a challenge for patients as well as healthcare professionals, but one that may become easier thanks to artificial intelli

News

Double ApoE4 gene a 'distinct form' of early Alzheimer’s

Having two copies of the ApoE4 gene is not just a risk factor for the development of Alzheimer’s, but is a likely cause of the disease, according to researchers in Spain.

News

Top charities team up with $300m for climate, health equity

The Novo Nordisk Foundation, the Bill & Melinda Gates Foundation, and Wellcome have joined forces to tackle some of the most pressing threats to human health and wellb

News

Price cut unlocks NHS use of sickle cell drug Oxbryta

It has been nearly two years since Pfizer’s sickle cell disease (SCD) therapy Oxbryta was approved in the UK, but patients will now be able to access the treatment after a

RNA blood test may predict antidepressant response

Pfizer pauses DMD gene therapy trial after boy’s death

Sorcero GenAI conjures plain language from scientific papers

Double ApoE4 gene a 'distinct form' of early Alzheimer’s

Top charities team up with $300m for climate, health equity

Price cut unlocks NHS use of sickle cell drug Oxbryta

ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o...

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks